Abstract:One promoter polymorphism, −174G/C, in interleukin-6 gene attracts special attention for its involvement in regulating transcription and association with hypertension by several studies. We first performed a case–control study investigating the association of this polymorphism with essential hypertension among Han Chinese (475 cases and 475 controls, matched for age and gender) from Shanghai, and then meta-analyzed all available evidence. Genotyping was done using PCR-RFLP techniques. Three genetic modes of inheritance were explored. As for meta-analysis, fixed-effects model was applied to pool data in the absence of between-studies heterogeneity, and random-effects model otherwise. Data and study quality were assessed in duplicate. Publication bias was evaluated using the fail-safe number. Our case–control study showed significant differences in the genotype/allele distributions of −174G/C polymorphism, and significance persisted under both additive and dominant modes. The following meta-analysis involving 1153 cases and 1291 controls supported the protective role of −174C allele (OR=0.77; 95% CI, 0.58 to 1.00; P=0.05), in line with the represent case–control results. In addition, significance was noted for the dominant effect (OR=0.69; 95% CI, 0.49 to 0.97; P<0.0001) rather than the recessive effect (OR=0.80; 95% CI, 0.56 to 1.13; P=0.20). The fail-safe number at the level of 0.05 was in favor of this positive association. Taken together, our case–control study and meta-analysis consistently support that the −174C allele was associated with a decreased risk to develop hypertension and this effect appeared to manifest in a dominant action. One promoter polymorphism, −174G/C, in interleukin-6 gene attracts special attention for its involvement in regulating transcription and association with hypertension by several studies. We first performed a case–control study investigating the association of this polymorphism with essential hypertension among Han Chinese (475 cases and 475 controls, matched for age and gender) from Shanghai, and then meta-analyzed all available evidence. Genotyping was done using PCR-RFLP techniques. Three genetic modes of inheritance were explored. As for meta-analysis, fixed-effects model was applied to pool data in the absence of between-studies heterogeneity, and random-effects model otherwise. Data and study quality were assessed in duplicate. Publication bias was evaluated using the fail-safe number. Our case–control study showed significant differences in the genotype/allele distributions of −174G/C polymorphism, and significance persisted under both additive and dominant modes. The following meta-analysis involving 1153 cases and 1291 controls supported the protective role of −174C allele (OR=0.77; 95% CI, 0.58 to 1.00; P=0.05), in line with the represent case–control results. In addition, significance was noted for the dominant effect (OR=0.69; 95% CI, 0.49 to 0.97; P<0.0001) rather than the recessive effect (OR=0.80; 95% CI, 0.56 to 1.13; P=0.20). The fail-safe number at the level of 0.05 was in favor of this positive association. Taken together, our case–control study and meta-analysis consistently support that the −174C allele was associated with a decreased risk to develop hypertension and this effect appeared to manifest in a dominant action.

Association and interaction analysis of NLRP3 gene polymorphisms with hypertension risk: a case–control study in China

Polymorphisms of Inflammation-Related Genes and Colorectal Cancer Risk: a Population-Based Case-Control Study in China.

Risk factors and gene polymorphisms of inflammatory bowel disease in population of Zhejiang, China.

Association of natriuretic peptide receptor-C gene with ischemic stroke and hypertension in Chinese Han population.

NALP3-Inflammasome-Related Gene Polymorphisms in Patients with Prehypertension and Coronary Atherosclerosis

TheNLRP3 Rs10754558polymorphism is Associated with the Occurrence and Prognosis of Coronary Artery Disease in the Chinese Han Population

Nlrp3 Polymorphisms Are Associated with Late-Onset Alzheimer'S Disease in Han Chinese

Comprehensive Assessment of the Association of WNK4 Polymorphisms with Hypertension: Evidence from a Meta-Analysis

Associations between polymorphisms of the CXCL12 and CNNM2 gene and hypertension risk: A case-control study

Association study between two novel single nucleotide polymorphisms and sporadic Parkinson's disease in Chinese Han population.

Association Analysis of WNT3, HLA-DRB5 and IL1R2 Polymorphisms in Chinese Patients With Parkinson’s Disease and Multiple System Atrophy

Impact of NLRP3 gene polymorphisms (rs10754558 and rs10733113) on HPV infection and cervical cancer in southern Chinese population

NLRP3 Influences Cognitive Function in Schizophrenia in Han Chinese

Association between single-nucleotide polymorphisms in six hypertensive candidate genes and hypertension among northern Han Chinese individuals

Interleukin-6 Promoter −174G/C Polymorphism and Hypertension: A Case–control Study and a Meta-Analysis

Do Genetic Defects of DNA Repair Relevant Proteins Alter Susceptibility to Hypertension? A Case-Control Study in Northeastern Han Chinese.

Two Polymorphisms in NEDD4L Gene and Essential Hypertension in Chinese Hans - a Population-Based Case-Control Study.

Associations Between Single Nucleotide Polymorphisms in Mir-221, Self-Reported Essential Hypertension, and Interactions Between Genetic and Environmental Factors: a Multiethnic Study in China.

Association between the interleukin-1β C(−511)T polymorphism and blood pressure in a Chinese hypertensive population

Validation of Genetic Association in Apelin–agtrl1 System with Hypertension in a Larger Han Chinese Population

Genetic Association Between the NLRP3 Gene and Acne Vulgaris in a Chinese Population